IDH1R132H mutation increases radiotherapy efficacy and a 4-gene radiotherapy-related signature of WHO grade 4 gliomas. - Han, Xuetao; Zhou, Huandi; Sun, Wei; Hou, Liubing; Wang, Yanqiang; Wang, Hong; Lv, Zhongqiang; Xue, Xiaoying (Scientific Reports, 2023)